dc.creatorDalpino, F
dc.creatorSodre, FL
dc.creatorCastilho, LN
dc.creatorde Faria, EC
dc.date2005
dc.dateSEP
dc.date2014-07-30T14:38:59Z
dc.date2015-11-26T16:42:43Z
dc.date2014-07-30T14:38:59Z
dc.date2015-11-26T16:42:43Z
dc.date.accessioned2018-03-28T23:27:23Z
dc.date.available2018-03-28T23:27:23Z
dc.identifierAnnals Of Clinical Biochemistry. Royal Soc Medicine Press Ltd, v. 42, n. 398, n. 399, 2005.
dc.identifier0004-5632
dc.identifierWOS:000232246000012
dc.identifier10.1258/0004563054889918
dc.identifierhttp://www.repositorio.unicamp.br/jspui/handle/REPOSIP/61339
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/61339
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1273352
dc.descriptionBackground: Lipoprotein(a) (Lp(a)) is an independent risk factor for coronary artery diseases. The main objective of this work was to evaluate the determinants of plasma Lp(a) concentrations in normolipidaemic individuals. Methods: Immunonephelometric quantification of Lp(a) was made in 177 volunteers. A multivariate analysis was employed to verify the influence of clinical and biochemical parameters on plasma Lp(a) concentration. Results: The serum Lp(a) concentration in this population ranged from 0.7 to 40 nmol/L. The Lp(a) predictors were: sex (female), HDL2 triglyceride (negative) and LDL-cholesterol (positive). Conclusions: The modulation of plasma Lp(a) concentration in this study points to pro-atherogenic lipoprotein associations.
dc.description42
dc.description5
dc.description398
dc.description399
dc.languageen
dc.publisherRoyal Soc Medicine Press Ltd
dc.publisherLondon
dc.publisherInglaterra
dc.relationAnnals Of Clinical Biochemistry
dc.relationAnn. Clin. Biochem.
dc.rightsfechado
dc.sourceWeb of Science
dc.subjectPopulation
dc.subjectDisease
dc.titleDeterminants of serum lipoprotein(a) concentration in normolipidaemic individuals without clincal atherosclerosis
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución